November 16, 2026
As biologic and targeted therapies continue to expand, dermatologists have new opportunities to tailor infectious disease screening to each patient and each agent. Hear from Theodore Rosen, MD, FAAD, as he joins Sanna Ronkainen, MD, FAAD, to share practical guidance on confirming the diagnosis, selecting pre-treatment testing for TNF-α, IL-17, IL-23, and JAK inhibitors, and recognizing infections that emerge during therapy.
This episode has been supported by an educational grant from Johnson and Johnson. The American Academy of Dermatology retains control over the episode content and interview participant selection.